17 November, 2026

The ACPSEM Radiopharmaceutical Science Community of Practice invites you to join a webinar presented by Dr Kenneth Kam Chung Hong on the development of [18F]Fluoroestradiol ([18F]FES), a PET radiopharmaceutical used to image tumour estrogen receptor activity in breast cancer.
This presentation will explore the radiochemistry behind [18F]FES production, including its synthesis on the Trasis AllInOne automated synthesiser. Dr Hong will discuss the role of [18F]FES in detecting and evaluating estrogen receptor-positive lesions, its increasing clinical importance in recurrent and metastatic breast cancer, and preliminary results from its local development and implementation.
Dr Kenneth Kam Chung Hong completed his PhD in Synthetic Organic Chemistry at UNSW Sydney and is a certified Radiopharmaceutical Science Specialist registered with ACPSEM. He holds a joint appointment between Prince of Wales Hospital and the Biological Resources Imaging Laboratory (BRIL) at UNSW Sydney. His work focuses on radiopharmaceutical development, automation, process optimisation, and clinical translation, and he has contributed to the implementation of several novel radiopharmaceuticals in Australia.
We encourage researchers, clinicians, radiochemists, and imaging professionals with an interest in radiopharmaceutical science to attend.
Join Here: https://teams.microsoft.com/meet/442383873625055?p=wgCM7xWhO3cdJBu8G6